TVTX
TVTX
NASDAQ · Biotechnology

Travere Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$44.12
+2.00 (+4.75%)
As of May 9, 1:26 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 18 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target -15.8% upside
Low Target $26.93
Average Target $37.15
High Target $48.45
Current Price $44.12
Current
$44.12
Target
$37.15
$26.93 $37.15 avg $48.45
Scenario Analysis
Bear Case
$26.93
-39.0%
Low target
Base Case
$37.15
-15.8%
Avg target
Bull Case
$48.45
+9.8%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$48.61
-9.2% from high
52-Week Low
$13.88
+217.9% from low
50-Day SMA
$32.84
+34.3% vs SMA
200-Day SMA
$24.79
+78.0% vs SMA
RSI (14)
40.3
Neutral
Target vs 52W High
$37.15
-23.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%